EN
HI

Vivanza Biosciences Share price

VIVANZA

2.05

0.03 (-1.44%)
Last updated on 3 Oct, 2025 | 15:29 IST
BUYSELL
Today's High

2.10

Today's Low

2.04

52 Week Low

1.90

52 Week High

4.36

The current prices are delayed, login to your account for live prices

Vivanza Biosciences Share Key Metrics

Volume
25505.00
Market Cap
8.32 CR
LTQ@LTP
180@2.05
ATP
2.06
Var Margin
25 %
Circuit Range
1.98-2.18
Delivery %
0 %
Value
52540.30
ASM/GSM
No
Market Lot
1

Vivanza Biosciences Fundamentals

View More
P/E Ratio

0

P/B Ratio

2.03

Div. Yield

0

Sector P/E

38.65

Sector P/B

2.54

Sec. Div. Yield

94.54

Vivanza Biosciences Resistance and Support

Pivot 2.11

Resistance

First Resistance

2.17

Second Resistance

2.25

Third Resistance

2.31

Support

First Support

2.03

Second Support

1.97

Third Support

1.89

Vivanza Biosciences Futures & Options

Data Not Found

Vivanza Biosciences Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

20.02%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

79.98%

Others

0%

Total Promoters
MAR '25
20.02%
JUN '25
20.02%

Vivanza Biosciences Corporate Actions

DateAgenda
2025-09-01Others
2025-08-13Quarterly Results
2025-05-12Audited Results
2025-01-31Quarterly Results & Others
2024-10-17Quarterly Results
2024-08-08Quarterly Results

Vivanza Biosciences News

No Data Found

About Vivanza Biosciences

NSE : 0  
BSE : 530057  
ISIN : INE984E01035  

Ivee Injectaa Limited is an existing closely-heldprofit-making Company presently engaged in the manufacture ofLarge Volume Parenterals (LVPs) with an installed capacity of 18lac units per annum at Village Sabalpur Junagadh DistrictGujarat. The Company was incorporated as Ivee Injectaa PrivateLimited on the 6th March 1982 and subsequently converted intoa Public Limited Company on the 11th May 1992.The Company now proposes to expand its existing installedcapacity to manufacture Large Volume Parenterals from 18 lacunits per annum to 54 lac units per annum and to diversify intothe manufacture of Small Volume Parenterals (SVP) with aninstalled capacity of 294 lac unit per annum.

Read More

Vivanza Biosciences Management

NamePosition
Mr. J A Mehta Managing Director
Mr. H A Parikh Director
View More

Vivanza Biosciences FAQs

The Buying Price of Vivanza Biosciences share is 2.05 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Vivanza Biosciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Vivanza Biosciences, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Vivanza Biosciences shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Vivanza Biosciences shares is 2.03. Useful to assess the stock's value relative to its book value.

To assess Vivanza Biosciences’s valuation compare Sector P/E, P/B which are 38.65 & 2.54 with sector averages, along with growth rates and financial metrics.

The Market Cap of Vivanza Biosciences is 8.32 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Vivanza Biosciences share price is 4.36 & 1.90. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Vivanza Biosciences belongs to the Miscellaneous sector.